+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
La Jolla Pharmaceutical Company - logo
Hypotension - Pipeline Review, H2 2019 - Product Thumbnail Image

Hypotension - Pipeline Review, H2 2019

  • Drug Pipelines
  • August 2019
  • 54 Pages
  • Global
From
Activin Receptor Type 1 - Pipeline Review, H1 2020 - Product Thumbnail Image

Activin Receptor Type 1 - Pipeline Review, H1 2020

  • Drug Pipelines
  • February 2020
  • 70 Pages
  • Global
From
Thalassemia Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Thalassemia Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • May 2020
  • 307 Pages
  • Global
From
Sepsis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Sepsis Therapeutics - Global Strategic Business Report

  • Report
  • February 2023
  • 291 Pages
  • Global
From
Sepsis - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Sepsis - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Septic Shock - Pipeline Insight, 2022 - Product Thumbnail Image

Septic Shock - Pipeline Insight, 2022

  • Clinical Trials
  • June 2022
  • 60 Pages
  • Global
From
PharmSource - Catching the Next Wave: How Much Have CMOs Benefited from Biosimilars - 2018 Edition - Product Thumbnail Image

PharmSource - Catching the Next Wave: How Much Have CMOs Benefited from Biosimilars - 2018 Edition

  • Report
  • December 2018
  • 74 Pages
  • Global
From
La Jolla Pharmaceutical Company (LJPC:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

La Jolla Pharmaceutical Company (LJPC:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • June 2021
  • 90 Pages
From
La Jolla Pharmaceutical Co. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

La Jolla Pharmaceutical Co. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • May 2023
  • 50 Pages
From
La Jolla Pharmaceutical Company (LJPC) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

La Jolla Pharmaceutical Company (LJPC) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • July 2022
  • 47 Pages
From
Loading Indicator